Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Blue Jet Healthcare shares rally 9% after Rs 800 crore QIP allotment
Blue Jet Healthcare shares rose sharply on Friday after the company completed its Rs 800 crore QIP, attracting marquee institutional investors, including multiple ICICI Prudential Mutual Fund schemes. The fund raise is expected to strengthen the company's balance sheet, support expansion plans, and boost long-term growth prospects while broadening its institutional shareholder base.
Stocks to buy or sell: Dharmesh Shah of ICICI Sec suggests buying Shriram Finance, Piramal Pharma shares on 6 July
Indian benchmark indices, Sensex and Nifty 50, opened higher on July 6, driven by gains in private banking stocks following strong quarterly updates from HDFC Bank and Axis Bank. Market breadth was positive with 14 of the 16 major indices in the green.
Sensex Today | Stock Market LIVE Updates: GIFT Nifty hints at a negative start; Sona BLW in focus
Sensex Today | Stock Market LIVE Updates: Nearly the entire market has reported its business update for the first quarter over the weekend, with companies ranging from banks, FMCG and even the diagnostics space. The bulls will take comfort from the fact that gains of the last two sessions have come without banks doing the heavy lifting.
Prudential HCL Health Insurance gets IRDAI nod
India's health insurance sector welcomes a new player as Prudential HCL Health Insurance receives regulatory approval. This joint venture, backed by Prudential Group Holdings and HCL Group, aims to tap into the growing demand for medical cover. The approval also signals broader regulatory changes, including new accounting standards and a policyholder protection fund. Prudential's presence in India is significantly expanding with this new health insurance arm.
Nifty 50 index slides below 23,950 level; auto shares outperform as Maruti Suzuki leads charge
The key equity benchmarks continued to trade below the flat line in afternoon trade. The Nifty 50 index traded below the 23,950 level. Auto, pharma and realty index advanced while IT, banks and FMCG stocks declined.
Healthcare, banks and EVs remain long-term bets: Invesco Mutual Fund's Taher Badshah
Taher Badshah, Chief Investment Officer at Invesco Mutual Fund, expects EV adoption to increase gradually with policy support, while opportunities are emerging in power distribution alongside transmission. Badshah also said SIP inflows remain stable and mutual fund industry trends are not showing signs of concern.
HDFC Mutual Fund buys additional 10 lakh shares of Global Health for Rs 130 crore
HDFC Mutual Fund has secured an additional 10 lakh shares of Global Health, which is known for operating Medanta hospitals, from co-founder Sunil Sachdeva for Rs 130 crore. This acquisition builds on a prior purchase made last month. The transaction accounts for a 0.37% stake in the company. In related news, Global Health has reported an impressive 39.7% increase in its fourth-quarter profit after tax, totaling Rs 141.7 crore.
Sensex rises 291 points, Nifty tops 24,100 on cooling crude and FII support
Domestic equities advanced on Monday as cooling oil prices and fresh FII inflows fuelled risk appetite. Buying in heavyweight Reliance Industries and healthcare counters propelled the Nifty past the 24,100 level. The gains were partly offset by weakness in consumer durables and FMCG stocks.
Sensex rises 291 points, Nifty tops 24,100: 5 key drivers behind the market rally
Sensex rose 291 to 77094, Nifty gained 90 to 24102, led by HDFC Bank, ICICI Bank, Reliance Industries, Infosys, with IT and pharma stocks like Cipla outperforming
Societe General, Prudential, others buy 3 per cent stake in Anthem Biosciences for Rs 1,275 cr
Global investors including Societe Generale and Prudential Hong Kong, alongside Indian mutual funds and insurance companies, have bought a 3 percent stake in Anthem Biosciences. The deal, valued at Rs 1,275 crore, saw promoter Aruna Ganesh exit the company. This significant transaction reshapes the promoter's holding in the integrated Contract Research, Development and Manufacturing Organisation.
HDFC MF, ADIA among buyers as Sepia Investments offloads Rs 749 crore in Corona Remedies via block deal
Sepia Investments and Anchor Partners sold shares worth about Rs 777 crore in Corona Remedies through block deals. HDFC Mutual Fund emerged as the largest buyer, while several institutional investors, including Aberdeen entities, ADIA, Invesco and WhiteOak, also accumulated stakes.
PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stake
Private equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per share. Despite this divestment, analysts remain positive on Emcure's growth outlook across its core therapeutic segments.